The team of Prof. Zhenjun Yang has made new progress in the in vivo delivery of  c-di-GMP and its analogues and the mechanism of tumor immunity

Journal of Chinese Pharmaceutical Sciences ›› 2022, Vol. 31 ›› Issue (10): 799-799.

• News • Previous Articles Next Articles

The team of Prof. Zhenjun Yang has made new progress in the in vivo delivery of c-di-GMP and its analogues and the mechanism of tumor immunity

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2022-10-26 Revised:2022-10-26 Accepted:2022-10-26 Online:2022-10-31 Published:2022-11-12

Abstract

Supporting:

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The team of Prof. Zhenjun Yang has made new progress in the in vivo delivery of c-di-GMP and its analogues and the mechanism of tumor immunity[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(10): 799-799.

The team of Prof. Zhenjun Yang has made new progress in the in vivo delivery of c-di-GMP and its analogues and the mechanism of tumor immunity

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments